Citi analyst Ephrem Ravi maintained a Buy rating on ArcelorMittal (0RP9 – Research Report) yesterday and set a price target of €40.00.
Trinity Biotech PLC ( NASDAQ:TRIB) reported a 3% year-on-year revenue growth, driven by TrinScreen HIV revenues. The company is making significant progress in the development of its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback